Proteus Digital Health Inc CEO and leadership

Andrew Thompson is a Silicon Valley based Chief Executive, entrepreneur and investor with a 30-year track record of successful technology-based innovation. As a Founder and Chief-Executive he has raised over $750M in private, public and corporate capital for first-in-category companies and personally negotiated three successful M&A transactions with Fortune 50 enterprises. In 2011 he was profiled by Adam Bryant in the New York Times “Corner Office”: (https://www.nytimes.com/2011/09/18/business/andrew-thompson-of-proteus-on-direct-feedback.html). From 2003 to 2020 he was Co-Founder, Chief Executive and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs. From 1994 to 1999 he was Co-Founder, Chief Executive and Board Member of FemRx, a pioneer of innovative solutions for women’s health, completing a NASDAQ IPO and subsequent sale to J&J. From 1991 to 1993 he was Co-Founder and Chief Financial Officer of CardioRhythm, a leader in minimally invasive arrhythmia surgery, acquired by Medtronic. From 1992 to 1995 he was Chairman of the Board at Kistler Morse, leading a turn-around and sale of the company to Danaher. Thompson is also accomplished at using technology to innovate in the public sector. Since 2002 he has been Co-Founder and Board Member of Summit Schools, a leading Charter School organization with a unique digital platform, featured in the Davis Guggenheim movie “Waiting for Superman”. Since 2004 he has worked in digital humanities innovation as a member of the Stanford University Libraries Board and was a co-founder of Parker Library Online, a leading destination for digital medieval studies. He is actively engaged with government leaders in Estonia, the most digitally enabled society in the world, with 2000 government services delivered from a single secure spine. Andrew Thompson is widely recognized as a thought leader in healthcare and technology. From 2009 he has been a presenter for the World Economic Forum; he served on the California Health IT Security Advisory Board; is a Commissioner of the United States National Council on Competitiveness; an Associate of Oxford University’s Creative Destruction Lab and an Advisor to private companies. He holds masters’ degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and is a named inventor on over 50 issued patents.

Dr. Mark Zdeblick J. is a Founder, Chief Technology Officer at Proteus Digital Health Inc and is based in United States.

Andrew Thompson is a Silicon Valley based Chief Executive, entrepreneur and investor with a 30-year track record of successful technology-based innovation. As a Founder and Chief-Executive he has raised over $750M in private, public and corporate capital for first-in-category companies and personally negotiated three successful M&A transactions with Fortune 50 enterprises. In 2011 he was profiled by Adam Bryant in the New York Times “Corner Office”: (https://www.nytimes.com/2011/09/18/business/andrew-thompson-of-proteus-on-direct-feedback.html). From 2003 to 2020 he was Co-Founder, Chief Executive and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs. From 1994 to 1999 he was Co-Founder, Chief Executive and Board Member of FemRx, a pioneer of innovative solutions for women’s health, completing a NASDAQ IPO and subsequent sale to J&J. From 1991 to 1993 he was Co-Founder and Chief Financial Officer of CardioRhythm, a leader in minimally invasive arrhythmia surgery, acquired by Medtronic. From 1992 to 1995 he was Chairman of the Board at Kistler Morse, leading a turn-around and sale of the company to Danaher. Thompson is also accomplished at using technology to innovate in the public sector. Since 2002 he has been Co-Founder and Board Member of Summit Schools, a leading Charter School organization with a unique digital platform, featured in the Davis Guggenheim movie “Waiting for Superman”. Since 2004 he has worked in digital humanities innovation as a member of the Stanford University Libraries Board and was a co-founder of Parker Library Online, a leading destination for digital medieval studies. He is actively engaged with government leaders in Estonia, the most digitally enabled society in the world, with 2000 government services delivered from a single secure spine. Andrew Thompson is widely recognized as a thought leader in healthcare and technology. From 2009 he has been a presenter for the World Economic Forum; he served on the California Health IT Security Advisory Board; is a Commissioner of the United States National Council on Competitiveness; an Associate of Oxford University’s Creative Destruction Lab and an Advisor to private companies. He holds masters’ degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and is a named inventor on over 50 issued patents.

Dr. Mark Zdeblick J. is a Founder, Chief Technology Officer at Proteus Digital Health Inc and is based in United States.

Andrew Thompson is a Silicon Valley based Chief Executive, entrepreneur and investor with a 30-year track record of successful technology-based innovation. As a Founder and Chief-Executive he has raised over $750M in private, public and corporate capital for first-in-category companies and personally negotiated three successful M&A transactions with Fortune 50 enterprises. In 2011 he was profiled by Adam Bryant in the New York Times “Corner Office”: (https://www.nytimes.com/2011/09/18/business/andrew-thompson-of-proteus-on-direct-feedback.html). From 2003 to 2020 he was Co-Founder, Chief Executive and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs. From 1994 to 1999 he was Co-Founder, Chief Executive and Board Member of FemRx, a pioneer of innovative solutions for women’s health, completing a NASDAQ IPO and subsequent sale to J&J. From 1991 to 1993 he was Co-Founder and Chief Financial Officer of CardioRhythm, a leader in minimally invasive arrhythmia surgery, acquired by Medtronic. From 1992 to 1995 he was Chairman of the Board at Kistler Morse, leading a turn-around and sale of the company to Danaher. Thompson is also accomplished at using technology to innovate in the public sector. Since 2002 he has been Co-Founder and Board Member of Summit Schools, a leading Charter School organization with a unique digital platform, featured in the Davis Guggenheim movie “Waiting for Superman”. Since 2004 he has worked in digital humanities innovation as a member of the Stanford University Libraries Board and was a co-founder of Parker Library Online, a leading destination for digital medieval studies. He is actively engaged with government leaders in Estonia, the most digitally enabled society in the world, with 2000 government services delivered from a single secure spine. Andrew Thompson is widely recognized as a thought leader in healthcare and technology. From 2009 he has been a presenter for the World Economic Forum; he served on the California Health IT Security Advisory Board; is a Commissioner of the United States National Council on Competitiveness; an Associate of Oxford University’s Creative Destruction Lab and an Advisor to private companies. He holds masters’ degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and is a named inventor on over 50 issued patents.